FDA approves reduced-dose pediatric asthma inhaler
The Food and Drug Administration approved Schering-Plough's Asmanex Twisthaler (mometasone furoate inhalation powder) in a 110-mcg formulation, for preventative asthma therapy for children 4 to 11 years of age....
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Recent Videos
Related Content
